Arab Finance: Memphis Pharmaceutical and Chemical Industries’ first phase of capital increase subscription has been covered by 93.78% at a total value of EGP 160.601 million, as per a disclosure.

Accordingly, 16.06 million shares were covered, with the remaining uncovered shares amounting to 1.065 million.

On August 7^th, The Egyptian Exchange’s (EGX) listing committee approved listing an increase of EGP 171.25 million for Memphis Pharmaceutical and Chemical Industries.

Memphis is one of the oldest pharmaceutical and chemical companies in the Middle East and has been in the market since 1940.

Memphis Pharmaceutical’s profits rise 112%YoY in FY 2023/24 Updated 9/11/2024 10:46:00 AM

EGX greenlights listing EGP 27.556M capital increase for Mansourah Poultry Updated 9/4/2024 9:17:00 AM

EGX approves listing Memphis Pharmaceuticals’ EGP 171.25M capital increase Updated 8/7/2024 9:21:00 AM

Memphis Pharmaceutical’s profits soar 115% YoY in FY2023/24 Updated 7/31/2024 11:46:00 AM

IFAP’s EGM nods to capital increase Updated 7/28/2024 2:27:00 AM